Dragonfly Therapeutics
Dragonfly Therapeutics is a clinical-stage biotechnology company based in Waltham, Massachusetts, founded in 2016 by Tyler Jacks, Bill Haney and David Raulet to develop natural killer (NK) cell-based immunotherapies. Its proprietary TriNKET (Tri-specific NK cell Engager Therapy) and cytokine engager platforms produce molecules that bind both a tumor or disease antigen and an NK cell activating receptor, recruiting innate and adaptive immunity against cancer, autoimmune disease, fibrosis and neuro-inflammation. Lead clinical candidate DF1001 targets HER2 in advanced solid tumors, and the platform is licensed under multi-target collaborations with AbbVie, Bristol Myers Squibb, Merck and Gilead. Dragonfly is a therapeutics developer rather than a software company: it publishes no developer program, no public API, no SDKs and no machine-readable API contract. The only agent-readable surfaces on its own host are the llms.txt and Model Context Protocol endpoint automatically provisioned by its Wix website platform.
Dragonfly Therapeutics is listed with 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Immunotherapy, and Oncology.
Dragonfly Therapeutics’ developer surface includes engineering blog, product news, authentication, and 11 more developer resources.
Kin Score
Standards implemented 2
Standards this provider implements or carries. De facto ones are profiled and measured by the API Commons; formal ones come from the standards directory and are linked by the provider's own tags. The evidence column says how each claim was established — not that it was made.
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
Dragonfly Therapeutics Site MCP
Model Context Protocol endpoint served from the Dragonfly Therapeutics website host. This is a platform-provided surface automatically provisioned by Wix for every site it build...
MCP Servers 1
Model Context Protocol servers that expose these APIs to AI agents.
Dragonfly Therapeutics MCP Server
Remote MCP server at www.dragonflytx.com over HTTP; 9 tools listed.
MCP SERVERDragonfly Therapeutics API pricing
Pricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Dragonfly Therapeutics Rate Limits
RATE LIMITSSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
Dragonfly Therapeutics API — frequently asked questions
Does Dragonfly Therapeutics have an API?
Yes. APIs.io lists 1 API from Dragonfly Therapeutics, including Dragonfly Therapeutics Site MCP.
How do I authenticate with the Dragonfly Therapeutics API?
Dragonfly Therapeutics uses bearer-token authentication (none/bearer-visitor-token · 2 schemes). The details are profiled on APIs.io as Dragonfly Therapeutics Authentication.
Does Dragonfly Therapeutics have an MCP server?
Yes. APIs.io lists 1 MCP server for Dragonfly Therapeutics: Remote MCP server at www.dragonflytx.com over HTTP; 9 tools listed.
Is the Dragonfly Therapeutics API ready for AI agents?
Dragonfly Therapeutics has a Kin Score of 15.0 out of 100 (emerging) and an Agent Readiness score of 7.2 (agent-aware), scored by API Evangelist on 2026-11-06.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.